Roche Holding AG
- Country
- π¨πSwitzerland
- Ownership
- Public
- Established
- 1896-01-15
- Employees
- 103.6K
- Market Cap
- $270.5B
- Website
- http://www.roche.com
- Introduction
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.
A Study to Compare Two Anti-HIV Drug Combinations
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 146
- Registration Number
- NCT00002447
- Locations
- πΊπΈ
UCSF - San Francisco Gen Hosp, San Francisco, California, United States
πΊπΈSaint Michael's Med Ctr / Dept of Infectious Diseases, Newark, New Jersey, United States
πΊπΈAssociates in Research, Fort Myers, Florida, United States
T-20 With Anti-HIV Combination Therapy for Patients With Prior Anti-HIV Drug Treatment and/or Drug Resistance to Each of the Three Classes of Approved Anti-HIV Drugs
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 525
- Registration Number
- NCT00008528
- Locations
- πΊπΈ
Massachusetts Gen Hosp, Boston, Massachusetts, United States
πΊπΈNicholas Bellos, Dallas, Texas, United States
πΊπΈUniv of Texas Med Branch, Galveston, Texas, United States
A Study of Saquinavir and Zalcitabine, Used Alone and Together, in the Treatment of Advanced HIV Infection in Patients Who Stopped Taking or Who Cannot Take Zidovudine
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 900
- Registration Number
- NCT00002333
- Locations
- πΊπΈ
Univ of Miami Dept of Medicine, Miami, Florida, United States
πΊπΈSunnyvale Med Clinic, Sunnyvale, California, United States
πΊπΈRush Presbyterian - Saint Luke's Med Ctr, Chicago, Illinois, United States
T-20 in HIV Patients With Prior Drug Treatment and/or Resistance to Each of the Three Classes of Anti-HIV Drugs
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 525
- Registration Number
- NCT00021554
- Locations
- π³π±
Natac Med Centre, Amsterdam, Netherlands
π³π±Univ Medical Center Utrecht, CX Utrecht, Netherlands
π¨πUniv Hosp Basel / Med Outpatient Dept, Basel, Switzerland
A Comparison of Three Anti-HIV Drug Combinations Containing Saquinavir Soft Gelatin Capsules Used in HIV-1 Infected Patients
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 825
- Registration Number
- NCT00002378
- Locations
- πΊπΈ
Northwestern Univ Med Ctr, Chicago, Illinois, United States
πΊπΈLehigh Valley Hosp, Allentown, Pennsylvania, United States
πΊπΈNorth Texas Infectious Disease Consultants, Dallas, Texas, United States
A Study to Compare Three Doses of T-20 When Given in Combination With Abacavir, Amprenavir, Ritonavir, and Efavirenz to HIV-Infected Adults
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-11-15
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 68
- Registration Number
- NCT00002239
- Locations
- πΊπΈ
UCLA Care Ctr, Los Angeles, California, United States
πΊπΈAIDS Research Consortium of Atlanta, Atlanta, Georgia, United States
πΊπΈPennsylvania Oncology and Hematology Associates, Philadelphia, Pennsylvania, United States
Safety and Effectiveness of Adding Saquinavir (FORTOVASE) in Soft Gel Capsule Form to an Anti-HIV Drug Combination in HIV-Infected Patients
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 80
- Registration Number
- NCT00002229
- Locations
- πΊπΈ
Univ of Illinois Hosp at Chicago, Chicago, Illinois, United States
π΅π·Programe DeSIDA De San Juan, San Turce, Puerto Rico
πΊπΈUniv of Virginia Health Sciences Ctr, Charlottesville, Virginia, United States
A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Large Intestine in Patients With AIDS
- Conditions
- ColitisHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Hoffmann-La Roche
- Registration Number
- NCT00002273
- Locations
- πΊπΈ
Roche Global Development - Palo Alto, Palo Alto, California, United States
A Study of Saquinavir Soft Gelatin Capsules Combined With Other Anti-HIV Drugs in HIV-1 Infected Patients
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 120
- Registration Number
- NCT00002374
- Locations
- πΊπΈ
Ctr for Quality Care, Tampa, Florida, United States
πΊπΈAIDS Ctr, New York, New York, United States
πΊπΈPacific Oaks Med Ctr, Beverly Hills, California, United States
A Randomized Controlled Study of the Efficacy and Safety of Maintenance Treatment With Oral Ganciclovir for Newly Diagnosed Cytomegalovirus Retinitis in People With AIDS
- Conditions
- Cytomegalovirus RetinitisHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 150
- Registration Number
- NCT00002257
- Locations
- π¨π¦
Saint Paul's Hosp, Vancouver, British Columbia, Canada
πΊπΈNew York Univ Med Ctr, New York, New York, United States
πΊπΈBeth Israel Deaconess Med Ctr, Boston, Massachusetts, United States